PATHOS

Trial description
A Phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV)-positive oropharyngeal cancer
Contact name
Dr Ekpemi Irune
Trial start date
Friday, June 16, 2017
Trial end date
Thursday, February 28, 2019
Trial tumour type
Head & neck
Show on Radiotherapy
Yes